Analyst Consensus ?
ConsensusBuy45 ratings
Bullish3373.3%
Neutral920.0%
Bearish36.7%
FN2 Earnings Intelligence
Eli Lilly and Company (LLY) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 28, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Buy | Buy | Maintain | Jul 15, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jul 14, 2026 |
| UBS | Buy | Buy | Maintain | Jul 13, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jul 13, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 10, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 8, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 8, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 8, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 7, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 6, 2026 |
| Leerink Partners | Outperform | Outperform | Maintain | Jun 25, 2026 |
| Jefferies | Buy | Buy | Maintain | Jun 9, 2026 |
| Barclays | Overweight | Overweight | Maintain | May 5, 2026 |
| Wolfe Research | Outperform | Outperform | Maintain | May 4, 2026 |
| HSBC | Reduce | Hold | Downgrade | Mar 17, 2026 |
| Freedom Broker | Buy | Hold | Upgrade | Feb 10, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Feb 9, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Feb 5, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Dec 4, 2025 |
| Freedom Capital Markets | Hold | Buy | Downgrade | Nov 10, 2025 |
| Berenberg | Hold | Buy | Downgrade | Sep 17, 2025 |
| Goldman Sachs | Buy | Neutral | Upgrade | Apr 8, 2025 |
| Argus Research | Buy | Buy | Maintain | May 14, 2024 |
| Erste Group | Buy | Hold | Upgrade | Apr 3, 2024 |
| DZ Bank | Hold | Buy | Downgrade | Feb 21, 2024 |
| Daiwa Capital | Outperform | Buy | Maintain | Dec 21, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 9, 2023 |
| TD Cowen | Outperform | Outperform | Maintain | May 23, 2023 |
| SVB Securities | Outperform | Outperform | Maintain | May 1, 2023 |
| Societe Generale | Sell | Hold | Downgrade | Feb 16, 2023 |
| SVB Leerink | Outperform | Outperform | Maintain | Dec 16, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Dec 5, 2022 |
| Mizuho | Buy | Buy | Maintain | May 2, 2022 |
| CFRA | Hold | Hold | Maintain | Apr 24, 2020 |
| Bank of America | Neutral | Neutral | Maintain | Sep 10, 2019 |
| Edward Jones | Buy | Hold | Upgrade | Apr 24, 2019 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Leerink Swann | Market Perform | Market Perform | Maintain | Oct 23, 2017 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Nov 25, 2016 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jul 27, 2015 |
| PiperJaffray | Overweight | Overweight | Maintain | Jun 17, 2015 |
| Tigress Financial | Buy | Buy | Maintain | Aug 1, 2014 |
| MKM Partners | Neutral | Buy | Downgrade | Apr 23, 2014 |
| CLSA | Sell | Sell | Maintain | Jan 17, 2013 |
| Bank oferica | Buy | Buy | Maintain | May 7, 2012 |
Upside is calculated against the persisted previous close $1,197.53. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Bernstein | Analyst unavailable | $1,385 | $1,185.08 | +15.7% | Jul 14, 2026 |
| UBS | Analyst unavailable | $1,425 | $1,189.91 | +19.0% | Jul 13, 2026 |
| Guggenheim | Analyst unavailable | $1,273 | $1,188.58 | +6.3% | Jul 13, 2026 |
| UBS | Analyst unavailable | $1,370 | $1,222.12 | +14.4% | Jul 9, 2026 |
| Truist Financial | Analyst unavailable | $1,370 | $1,227.07 | +14.4% | Jul 8, 2026 |
| RBC Capital | Analyst unavailable | $1,500 | $1,229.22 | +25.3% | Jul 8, 2026 |
| Morgan Stanley | Terence Flynn | $1,347 | $1,235.56 | +12.5% | Jul 8, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $1,350 | $1,210.5 | +12.7% | Jul 6, 2026 |
| Leerink Partners | David Risinger | $1,232 | $1,117.26 | +2.9% | Jun 25, 2026 |
| Berenberg Bank | Kerry Holford | $1,135 | $1,111.67 | -5.2% | Jun 22, 2026 |
| Jefferies | Analyst unavailable | $1,350 | $1,143.35 | +12.7% | Jun 9, 2026 |
| HSBC | Analyst unavailable | $1,251 | $1,065 | +4.5% | May 26, 2026 |
| Leerink Partners | David Risinger | $1,119 | $1,065 | -6.6% | May 26, 2026 |
| Wolfe Research | Analyst unavailable | $1,350 | $1,037.82 | +12.7% | May 21, 2026 |
| Barclays | Emily Field | $1,400 | $967.93 | +16.9% | May 5, 2026 |
| Morgan Stanley | Analyst unavailable | $1,344 | $961.56 | +12.2% | May 1, 2026 |
| Cantor Fitzgerald | Carter Gould | $1,230 | $970.68 | +2.7% | May 1, 2026 |
| Morgan Stanley | Analyst unavailable | $1,327 | $939.31 | +10.8% | Apr 10, 2026 |
| Jefferies | Akash Tewari | $1,300 | $1,000.78 | +8.6% | Mar 13, 2026 |
| Deutsche Bank | James Shin | $1,285 | $990.31 | +7.3% | Mar 6, 2026 |
| Morgan Stanley | Terence Flynn | $1,313 | $972.5 | +9.6% | Mar 5, 2026 |
| RBC Capital | Trung Huynh | $1,250 | $1,042.15 | +4.4% | Feb 24, 2026 |
| Barclays | Analyst unavailable | $1,350 | $1,023.22 | +12.7% | Feb 19, 2026 |
| Loop Capital Markets | Ilya Zubkov | $1,200 | $1,025 | +0.2% | Feb 10, 2026 |
| Scotiabank | Analyst unavailable | $1,300 | $1,037.12 | +8.6% | Feb 5, 2026 |
| Truist Financial | Analyst unavailable | $1,281 | $1,027.51 | +7.0% | Feb 5, 2026 |
| Goldman Sachs | Analyst unavailable | $1,260 | $1,107.12 | +5.2% | Feb 5, 2026 |
| Wells Fargo | Mohit Bansal | $1,280 | $1,107.12 | +6.9% | Feb 5, 2026 |
| BMO Capital | Evan Seigerman | $1,300 | $1,107.12 | +8.6% | Feb 5, 2026 |
| Guggenheim | Analyst unavailable | $1,161 | $1,038.4 | -3.1% | Jan 20, 2026 |
| UBS | Michael Yee | $1,250 | $1,064.04 | +4.4% | Jan 6, 2026 |
| Leerink Partners | David Risinger | $1,234 | $1,080.36 | +3.0% | Jan 5, 2026 |
| Daiwa | Narumi Nakagiri | $1,230 | $1,062.71 | +2.7% | Dec 16, 2025 |
| Goldman Sachs | Analyst unavailable | $1,145 | $1,039.04 | -4.4% | Dec 15, 2025 |
| HSBC | Analyst unavailable | $1,070 | $981.67 | -10.6% | Dec 10, 2025 |
| BMO Capital | Analyst unavailable | $1,200 | $1,033.56 | +0.2% | Dec 4, 2025 |
| Guggenheim | Analyst unavailable | $1,163 | $1,046.12 | -2.9% | Dec 3, 2025 |
| BMO Capital | Evan Seigerman | $1,100 | $1,058.48 | -8.1% | Dec 2, 2025 |
| National Bank | Tim Anderson | $1,286 | $1,057.89 | +7.4% | Dec 1, 2025 |
| Bernstein | Analyst unavailable | $1,300 | $1,059.7 | +8.6% | Nov 24, 2025 |
| Morgan Stanley | Terence Flynn | $1,290 | $1,059.7 | +7.7% | Nov 24, 2025 |
| Truist Financial | Srikripa Devarakonda | $1,182 | $1,049.6 | -1.3% | Nov 19, 2025 |
| Loop Capital Markets | Ilya Zubkov | $950 | $969.84 | -20.7% | Nov 10, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $985 | $839.16 | -17.7% | Oct 31, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $925 | $845.72 | -22.8% | Oct 9, 2025 |
| Guggenheim | Q3 Mounjaro | $948 | $843.63 | -20.8% | Oct 8, 2025 |
| Berenberg Bank | Analyst unavailable | $830 | $760.13 | -30.7% | Sep 17, 2025 |
| Daiwa | Narumi Nakagiri | $700 | $701.23 | -41.5% | Aug 17, 2025 |
| Cantor Fitzgerald | Carter Gould | $825 | $660.26 | -31.1% | Aug 13, 2025 |
| Leerink Partners | Market Perform | $715 | $640.86 | -40.3% | Aug 7, 2025 |
| UBS | Trung Huynh | $1,050 | $823.62 | -12.3% | May 2, 2025 |
| HSBC | Analyst unavailable | $700 | $877.29 | -41.5% | Apr 28, 2025 |
| Morgan Stanley | Analyst unavailable | $1,146 | $912.76 | -4.3% | Mar 6, 2025 |
| Leerink Partners | Andrew Berens | $950 | $740.15 | -20.7% | Jan 17, 2025 |
| Berenberg Bank | Kerry Holford | $970 | $746.74 | -19.0% | Jan 16, 2025 |
| BMO Capital | Evan David Seigerman | $1,010 | $829.74 | -15.7% | Oct 31, 2024 |
| Leerink Partners | Andrew Berens | $990 | $932.06 | -17.3% | Oct 14, 2024 |
| Citigroup | Peter Verdult | $1,060 | $935.02 | -11.5% | Sep 13, 2024 |
| Morgan Stanley | Terence Flynn | $1,106 | $957.51 | -7.6% | Aug 27, 2024 |
| Berenberg Bank | Kerry Holford | $1,050 | $908.05 | -12.3% | Aug 14, 2024 |
| Deutsche Bank | James Shin | $1,025 | $891.68 | -14.4% | Aug 12, 2024 |
| Goldman Sachs | Chris Shibutani | $856 | $891.68 | -28.5% | Aug 9, 2024 |
| Wells Fargo | Mohit Bansal | $1,000 | $845.31 | -16.5% | Aug 9, 2024 |
| BMO Capital | Evan David Seigerman | $1,101 | $845.31 | -8.1% | Aug 9, 2024 |
| Bank of America Securities | Geoff Meacham | $1,150 | $845.31 | -4.0% | Aug 9, 2024 |
| Morgan Stanley | Terence Flynn | $1,083 | $939.78 | -9.6% | Jul 11, 2024 |
| Berenberg Bank | Kerry Holford | $1,000 | $939.78 | -16.5% | Jul 11, 2024 |
| Morgan Stanley | Terence Flynn | $1,023 | $906.15 | -14.6% | Jul 2, 2024 |
| Jefferies | Akash Tewari | $1,015 | $883.88 | -15.2% | Jun 24, 2024 |
| Jefferies | Akash Tewari | $957 | $837.29 | -20.1% | Jun 6, 2024 |
| Barclays | Geoff Meacham | $913 | $820.34 | -23.8% | Jun 3, 2024 |
| Goldman Sachs | Chris Shibutani | $785 | $818.41 | -34.4% | May 30, 2024 |
| Jefferies | Akash Tewari | $925 | $805.06 | -22.8% | May 23, 2024 |
| Jefferies | Akash Tewari | $915 | $770 | -23.6% | May 20, 2024 |
| Wells Fargo | Mohit Bansal | $875 | $771.12 | -26.9% | May 16, 2024 |
| Argus Research | David Toung | $840 | $757.7 | -29.9% | May 14, 2024 |
| BMO Capital | Evan Seigerman | $1,001 | $781.1 | -16.4% | May 1, 2024 |
| Cantor Fitzgerald | Louise Chen | $885 | $781.1 | -26.1% | Apr 30, 2024 |
| BMO Capital | Evan David Seigerman | $900 | $748.4 | -24.8% | Apr 18, 2024 |
| Deutsche Bank | James Shin | $535 | $706.2 | -55.3% | Feb 6, 2024 |
| Citigroup | Andrew Baum | $675 | $581.51 | -43.6% | Dec 28, 2023 |
| Morgan Stanley | David Phung | $673 | $601.49 | -43.8% | Oct 11, 2023 |
| Cantor Fitzgerald | Louise Chen | $630 | $526.4 | -47.4% | Aug 9, 2023 |
| Wells Fargo | Analyst unavailable | $360 | $337.54 | -69.9% | Feb 3, 2023 |
| Morgan Stanley | Analyst unavailable | $455 | $330.7 | -62.0% | Feb 3, 2023 |
| Barclays | Analyst unavailable | $400 | $366.71 | -66.6% | Jan 3, 2023 |
| Cowen & Co. | Cowen Cowen | $430 | $359.87 | -64.1% | Dec 17, 2022 |
| Leerink Partners | Analyst unavailable | $410 | $360.01 | -65.8% | Dec 16, 2022 |
| UBS | Analyst unavailable | $420 | $363.5 | -64.9% | Dec 15, 2022 |
| Morgan Stanley | Analyst unavailable | $440 | $361.99 | -63.3% | Dec 14, 2022 |
| Wells Fargo | Analyst unavailable | $375 | $370.1 | -68.7% | Dec 8, 2022 |
| Guggenheim | Analyst unavailable | $401 | $372.39 | -66.5% | Dec 7, 2022 |
| Morgan Stanley | Analyst unavailable | $446 | $368.01 | -62.8% | Dec 6, 2022 |
| Credit Suisse | Analyst unavailable | $400 | $367.74 | -66.6% | Dec 6, 2022 |
| Credit Suisse | Analyst unavailable | $395 | $360.77 | -67.0% | Nov 18, 2022 |
| Morgan Stanley | Analyst unavailable | $436 | $354.66 | -63.6% | Nov 17, 2022 |
| UBS | Colin Bristow Bristow | $336 | $323.35 | -71.9% | Oct 2, 2022 |
| UBS | Navin Jacob | $363 | $296.48 | -69.7% | Sep 22, 2022 |
| Morgan Stanley | Analyst unavailable | $412 | $310.91 | -65.6% | Sep 7, 2022 |
| BMO Capital | Analyst unavailable | $396 | $306.38 | -66.9% | Sep 6, 2022 |
| Morgan Stanley | Analyst unavailable | $395 | $327.95 | -67.0% | Jul 8, 2022 |
| Barclays | Analyst unavailable | $355 | $330.15 | -70.4% | Jul 7, 2022 |
| J.P. Morgan | Analyst unavailable | $355 | $307.73 | -70.4% | Jun 1, 2022 |
| Leerink Partners | David Risinger | $341 | $302.76 | -71.5% | May 23, 2022 |
| UBS | Navin Jacob | $293 | $289.23 | -75.5% | May 9, 2022 |
| BMO Capital | Evan David Seigerman | $358 | $296.9 | -70.1% | May 8, 2022 |
| Mizuho Securities | Vamil Divan | $356 | $289.56 | -70.3% | May 3, 2022 |
| Wells Fargo | Mohit Bansal | $305 | $292.13 | -74.5% | Apr 30, 2022 |
| Morgan Stanley | Analyst unavailable | $369 | $293.02 | -69.2% | Apr 29, 2022 |
| Morgan Stanley | Terence Flynn | $364 | $308.96 | -69.6% | Apr 11, 2022 |
| Bank of America Securities | Geoff Meacham | $315 | $289.02 | -73.7% | Mar 26, 2022 |
| Morgan Stanley | Matthew Harrison | $265 | $242.27 | -77.9% | Feb 6, 2022 |
| Cantor Fitzgerald | Louise Chen | $335 | $245.1 | -72.0% | Jan 30, 2022 |
| Wells Fargo | Mohit Bansal | $280 | $265.7 | -76.6% | Jan 4, 2022 |
| Bernstein | Aaron Gal | $300 | $270.6 | -74.9% | Jan 3, 2022 |
| Barclays | Carter Gould | $325 | $262.38 | -72.9% | Dec 20, 2021 |
| Goldman Sachs | Chris Shibutani | $236 | $266.31 | -80.3% | Dec 17, 2021 |
| J.P. Morgan | Chris Schott | $325 | $277.88 | -72.9% | Dec 16, 2021 |
| Citigroup | Andrew Baum | $265 | $244.09 | -77.9% | Dec 7, 2021 |
| UBS | Navin Jacob | $267 | $253.77 | -77.7% | Nov 29, 2021 |
| Guggenheim | Seamus Fernandez | $266 | $228.47 | -77.8% | Sep 21, 2021 |
| Cowen & Co. | Steve Scala | $300 | $260.37 | -74.9% | Aug 30, 2021 |
| Argus Research | David Toung | $300 | $264.33 | -74.9% | Aug 9, 2021 |
Track every rating change on LLY the moment it posts. Free to start.
Start free